Skip to content

Clinical trials

Completed Phase 1/2 Thrombocytopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 1/2 Status: Completed Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20052
20081
20091
20101
20141
20151
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Cairo University1
Case Comprehensive Cancer Center1
Centers for Disease Control and Prevention1
Children's Hospital Los Angeles1
Drexel University College of Medicine1
Groupe Francophone des Myelodysplasies1
M.D. Anderson Cancer Center1
Shandong University1
St. Jude Children's Research Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia12
Anemia3
Leukemia, Myelomonocytic, Chronic3
Anemia, Refractory2
Anemia, Refractory, with Excess of Blasts2
Leukemia2
Myelodysplastic Syndromes2
Neutropenia2
Anemia, Diamond-Blackfan1
Anemia, Dyserythropoietic, Congenital1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.